Investigations and deployment gaps
Avenues where the technology already works, but deployment, trust, incentives, or recognition have failed.
By Hand
6 min read
I am even writing the abstract myself.
WritingReflection
Hi, I'm Will — a developer in Spain, building and writing in public.
The cost of building software and doing research has collapsed. That part isn't news. What's less settled is where the collapse actually reaches the people who need it, and where it stalls. I've been investigating those gaps — sometimes building something to test an idea, sometimes the investigation is the point.
I do it in public because the reasoning is the useful part, not just the artifacts — and because it's work that wants more hands on it, not fewer.
Three threads run through the site
This is not just a thesis blog about overhang. It is a body of work across investigations, AI/philosophy, and practical building, all tied together by the question of what becomes possible when capability gets cheap and deployment still lags.
AI, meaning, and edge cases
Writing from inside the weirdness of living and building alongside AI systems, without pretending the questions are settled.
Build notes and practical making
Notes from building with new tools, where the practice is changing faster than the rules around it.
Start here
If you are new here, these four pieces are probably the fastest way to understand what I am doing and why.
Working Theory
The framing piece: what technological overhang is, and why I think it matters now.
What the Map Shows So Far
A synthesis of the investigations and what keeps repeating across very different domains.
What If I Am Delusional?
A self-skeptical AI piece about echo chambers, uncertainty, and why I still think this work is worth doing.
Prompts Are Source Code Now
A build-practice piece about what changes when prompt, code, and intent stop being cleanly separable.
Built from the research
Some investigations stop at clearer understanding. Some turn into tools. The point is not to separate ideas from products, but to make the investigate, write, and build loop visible.
Zebra Scout
Rare disease symptom matching from the diagnosis investigation.
Rightsclaim
EU consumer-rights claim drafting from the consumer-rights investigation.
RxLens
Pharmacogenomics report generation from the PGx investigation.
Retrofit
Energy-retrofit guidance from the housing and subsidy navigation work.
Recent writing
AI, software, ethics, society, and the occasional honest reckoning. Newest first.
Living the Overhang
3 min read
I spent months mapping places where technology works but deployment fails. Then I noticed I was doing the same thing.
TheoryAI
How I'm Deciding Where to Look Next
5 min read
Eight investigations in, I'm trying to be more systematic about choosing what to explore next.
AvenuesTheoryMethodology
Retrofit: The Subsidy Navigator Nobody Built
4 min read
Most Spanish homes are energy disasters — rated E, F, or G. Billions in EU retrofit subsidies exist. But the gap between "money is available" and "homeowner applies for it" is enormous, especially in small inland towns. This is a tool that tries to close it.
AvenuesTools
I Built a Pharmacogenomics Tool in 12 Minutes. I Wouldn't Use It.
7 min read
Sixty million people have genetic data that could change how their doctor prescribes medication. The tool to translate that data exists and took minutes to build. But the real question isn't "can we build it?" — it's "why would you trust it?" The answer points to a fundamental shift in what software is becoming.
AvenuesHealthcarePharmacogenomicsTrustSoftware
What the Map Shows So Far
6 min read
Eight investigations into why technology doesn't reach the people who need it. I'm not an expert in any of these domains. That's partly the point — the barrier to useful investigation has dropped. Here's what I found when I looked.
AvenuesTheory
Investigations
I've been looking at places where technology works but deployment has failed — asking why the gap persists and what, if anything, a single person can do about it. Eight so far. Here are a few.
Rare Disease Diagnosis
7,000 diseases, 400M people affected, 4.7-year average diagnosis. The databases exist. Nothing connects them to the patient.
Consumer Rights
EU rights are excellent on paper. Enforcement is terrible, because the friction is someone's business model.
Pharmacogenomics
60M people have genetic data that could change prescriptions. The tool took 12 minutes to build. The trust takes longer.
Desalination
Freshwater at $0.30/m³, technology works. In Punjab, auditors found 19 government plants. All non-functional.